Darifenacin: a selective M3 muscarinic receptor antagonist for the treatment of overactive bladder
such as dry mouth and constipation, limit the tolerability of antimuscarinic treatment. Therefore, a uroselective M3 receptor antagonist would be considered optimal therapy for overactive bladder. Darifenacin (Enablex…

